These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1749827)

  • 1. Clonidine and scopolamine: differences and similarities in how they change human information processing.
    Callaway E; Halliday R; Naylor H; Brandeis D
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(4):497-502. PubMed ID: 1749827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral scopolamine on human stimulus evaluation.
    Callaway E; Halliday R; Naylor H; Schechter G
    Psychopharmacology (Berl); 1985; 85(2):133-8. PubMed ID: 3925478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of clonidine and yohimbine on human information processing.
    Halliday R; Callaway E; Lannon R
    Psychopharmacology (Berl); 1989; 99(4):563-6. PubMed ID: 2594924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of D-amphetamine, clonidine, and yohimbine on human information processing.
    Halliday R; Naylor H; Brandeis D; Callaway E; Yano L; Herzig K
    Psychophysiology; 1994 Jul; 31(4):331-7. PubMed ID: 10690913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine effects on visual information processing, attention, and event-related potential map latencies.
    Brandeis D; Naylor H; Halliday R; Callaway E; Yano L
    Psychophysiology; 1992 May; 29(3):315-36. PubMed ID: 1626042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of clonidine and scopolamine on multiple target detection in rapid serial visual presentation.
    Brown SB; Slagter HA; van Noorden MS; Giltay EJ; van der Wee NJ; Nieuwenhuis S
    Psychopharmacology (Berl); 2016 Jan; 233(2):341-50. PubMed ID: 26507194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli.
    Brown SB; van der Wee NJ; van Noorden MS; Giltay EJ; Nieuwenhuis S
    Psychophysiology; 2015 Dec; 52(12):1620-31. PubMed ID: 26352794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine effects on ERPs and performance in an auditory Go/NoGo task.
    Barry RJ; Johnstone SJ; Clarke AR; Rushby JA; Brown CR; McKenzie DN
    Clin Neurophysiol; 2007 Dec; 118(12):2692-9. PubMed ID: 17905651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic and cholinergic effects on speed and sensitivity measures of phasic alerting.
    Brown SB; Tona KD; van Noorden MS; Giltay EJ; van der Wee NJ; Nieuwenhuis S
    Behav Neurosci; 2015 Feb; 129(1):42-9. PubMed ID: 25621791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.
    Parrott AC
    Psychopharmacology (Berl); 1986; 89(3):347-54. PubMed ID: 3088662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scopolamine Reduces Electrophysiological Indices of Distractor Suppression: Evidence from a Contingent Capture Task.
    Laube I; Matthews N; Dean AJ; O'Connell RG; Mattingley JB; Bellgrove MA
    Front Neural Circuits; 2017; 11():99. PubMed ID: 29270112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
    Duka T; Ott H; Rohloff A; Voet B
    Psychopharmacology (Berl); 1996 Feb; 123(4):361-73. PubMed ID: 8867876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic and serotonergic effects on the P3 potential and recent memory.
    Meador KJ; Loring DW; Davis HC; Sethi KD; Patel BR; Adams RJ; Hammond EJ
    J Clin Exp Neuropsychol; 1989 Mar; 11(2):252-60. PubMed ID: 2925834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of attenuating noradrenergic neurotransmission by clonidine on brain activity measures of visuospatial attention.
    Logemann HN; Böcker KB; Deschamps PK; Kemner C; Kenemans JL
    Hum Psychopharmacol; 2014 Jan; 29(1):46-54. PubMed ID: 24222260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of scopolamine on event-related potentials in a continuous recognition memory task.
    Potter DD; Pickles CD; Roberts RC; Rugg MD
    Psychophysiology; 1992 Jan; 29(1):29-37. PubMed ID: 1609025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in psychic performance with guanfacine and clonidine in normotensive subjects.
    Kugler J; Seus R; Krauskopf R; Brecht HM; Raschig A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):71S-80S. PubMed ID: 6994783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cholinergic systems and the P3 evoked potential.
    Meador KJ; Loring DW; Adams RJ; Patel BR; Davis HC; Hammond EJ
    Int J Neurosci; 1987 Apr; 33(3-4):199-205. PubMed ID: 3596949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction Time in a Visual 4-Choice Reaction Time Task: ERP Effects of Motor Preparation and Hemispheric Involvement.
    Antonova I; van Swam C; Hubl D; Dierks T; Griskova-Bulanova I; Koenig T
    Brain Topogr; 2016 Jul; 29(4):491-505. PubMed ID: 26830770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing.
    Turetsky BI; Fein G
    Psychophysiology; 2002 Mar; 39(2):147-57. PubMed ID: 12212663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo probe of central cholinergic systems.
    Meador KJ; Loring DW; Lee GP; Taylor HS; Hughes DR; Feldman DS
    J Gerontol; 1988 Nov; 43(6):M158-62. PubMed ID: 3183305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.